NEUROPACE INC (NPCE) Earnings History & Surprises

NASDAQ:NPCEUS6412881053

Current stock price

13.33 USD
-0.33 (-2.42%)
At close:
13.33 USD
0 (0%)
After Hours:

NPCE Earnings overview

Past quarterly earnings results for NEUROPACE INC (NPCE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.23
Revenue Estimate
22.077M

Last Reported

Most Recent
Release Date
Mar 3, 2026
Period
Q4 / 2025
EPS Reported
-$0.08
EPS Surprise
48.21%
Revenue Surprise
5.14%

Beat Rate

Last 8 Quarters
81%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.08 -0.15 48.21% 55.56% 26.588M 25.287M 5.14% 23.86%
Q3 2025 -0.11 -0.20 45.05% 42.11% 27.354M 25.127M 8.86% 29.89%
Q2 2025 -0.26 -0.23 -14.56% - 23.52M 23.547M -0.11% 22.14%
Q1 2025 -0.21 -0.25 14.72% 34.38% 22.524M 22.284M 1.08% 24.28%
Q4 2024 -0.18 -0.23 20.82% 21.74% 21.466M 21.596M -0.60% 19.18%
Q3 2024 -0.19 -0.27 30.58% 32.14% 21.06M 19.461M 8.22% 28.20%
Q2 2024 -0.26 -0.31 15.03% 27.78% 19.256M 18.663M 3.18% 16.63%
Q1 2024 -0.32 -0.33 2.47% 21.95% 18.124M 17.648M 2.70% 25.23%
Q4 2023 -0.23 -0.32 28.42% 48.89% 18.012M 17.806M 1.16% 40.83%
Q3 2023 -0.28 -0.42 33.05% 41.67% 16.427M 14.507M 13.23% 47.20%
Q2 2023 -0.36 -0.47 24.10% 30.77% 16.51M 12.878M 28.20% 61.86%
Q1 2023 -0.41 -0.47 11.85% 12.77% 14.472M 12.411M 16.61% 27.28%
Q4 2022 -0.45 -0.50 10.87% -2.27% 12.79M 12.645M 1.15% 16.27%
Q3 2022 -0.48 -0.54 10.65% -41.18% 11.16M 10.088M 10.63% 7.93%
Q2 2022 -0.52 -0.45 -14.99% -8.33% 10.2M 11.302M -9.75% -19.24%
Q1 2022 -0.47 -0.45 -4.13% 98.56% 11.37M 10.979M 3.56% 1.34%
Q4 2021 -0.44 -0.34 -30.72% - 11M 10.892M 0.99% -
Q3 2021 -0.34 -0.31 -9.65% - 10.34M 11.017M -6.15% -19.03%
Q2 2021 -0.48 -0.34 -39.78% - 12.63M 11.531M 9.53% -
Q1 2021 -32.73 -0.29 -11,360.08% - 11.22M 11.22M - -
Q3 2020 - - 12.77M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NPCE EPS Q2Q GrowthNPCE EPS Q2Q GrowthEPS Q2Q Growth Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 50 -50

Revenue Historical Q2Q growth and Acceleration

NPCE Revenue Q2Q GrowthNPCE Revenue Q2Q GrowthRevenue Q2Q Growth Q3/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 0 20 40 60

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
23.35%
Max EPS beat (4)
48.21%
Min EPS beat (4)
-14.56%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
3.74%
Max Revenue beat (4)
8.86%
Min Revenue beat (4)
-0.11%

Analysis

In the last 4 quarters, NPCE has beaten EPS estimates in 3 out of 4 releases
NPCE has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, NPCE has beaten the EPS estimates by 23.4% on average.
In the last 4 quarters, NPCE has beaten the revenue estimates by 3.7% on average.

NEUROPACE INC / NPCE Earnings FAQ

Can you provide the last earnings date for NEUROPACE INC?

NEUROPACE INC (NPCE) last reported earnings on 3/3/2026.

Did NEUROPACE INC (NPCE) beat earnings estimates last quarter?

NEUROPACE INC (NPCE) beat EPS estimates and beat revenue estimates in the most recent quarter.

How often does NEUROPACE INC (NPCE) beat earnings estimates?

In the last 4 quarters, NEUROPACE INC (NPCE) has beaten EPS estimates in 3 out of 4 releases.